Group One Trading’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-10,833
| Closed | -$66K | – | 9198 |
|
|
2021
Q3 | $66K | Buy |
10,833
+9,339
| +625% | +$58.2K | ﹤0.01% | 6321 |
|
|
2021
Q2 | $12K | Buy |
+1,494
| New | +$12.7K | ﹤0.01% | 7471 |
|
|
2019
Q4 | – | Sell |
-16,264
| Closed | -$274K | – | 5839 |
|
|
2019
Q3 | $223K | Buy |
16,264
+11,616
| +250% | +$138K | ﹤0.01% | 3006 |
|
|
2019
Q2 | $57K | Buy |
+4,648
| New | +$53.6K | ﹤0.01% | 3706 |
|
|
2019
Q1 | – | Sell |
-13,482
| Closed | -$180K | – | 5592 |
|
|
2018
Q4 | $153K | Buy |
13,482
+11,212
| +494% | +$176K | ﹤0.01% | 2886 |
|
|
2018
Q3 | $42K | Buy |
+2,270
| New | +$52.2K | ﹤0.01% | 4075 |
|
|
2018
Q2 | – | Sell |
-10,117
| Closed | -$263K | – | 5640 |
|
|
2018
Q1 | $227K | Buy |
10,117
+8,693
| +610% | +$212K | ﹤0.01% | 2698 |
|
|
2017
Q4 | $36K | Sell |
1,424
-4,947
| -78% | -$121K | ﹤0.01% | 3897 |
|
|
2017
Q3 | $154K | Buy |
+6,371
| New | +$150K | ﹤0.01% | 2950 |
|
|
2016
Q4 | – | Sell |
-152
| Closed | -$2.9K | – | 5000 |
|
|
2016
Q3 | $3K | Sell |
152
-60
| -28% | -$1.01K | ﹤0.01% | 4334 |
|
|
2016
Q2 | $3K | Sell |
212
-2,807
| -93% | -$35.3K | ﹤0.01% | 4393 |
|
|
2016
Q1 | $28K | Sell |
3,019
-2,800
| -48% | -$34K | ﹤0.01% | 3581 |
|
|
2015
Q4 | $112K | Buy |
5,819
+1,200
| +26% | +$20.8K | ﹤0.01% | 2915 |
|
|
2015
Q3 | $69K | Buy |
+4,619
| New | +$108K | ﹤0.01% | 3323 |
|
Group One Trading's FLXN Position: Q4 2021 in Review
Group One Trading sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 10,833 shares — an estimated $66K sold.
Group One Trading first reported a position in FLXN in Q3 2015 and held it in 14 quarters. The position peaked at $227K in Q1 2018. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.
- Group One Trading reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
- Group One Trading sold 10,833 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $66K.
- Group One Trading first reported a position in Flexion Therapeutics, Inc. in Q3 2015 and held it in 14 quarters.
- Group One Trading's Flexion Therapeutics, Inc. position peaked at $227K in Q1 2018.
- 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.
Based on Group One Trading's 13F filing for Q4 2021, filed 11 Feb 2022.